C&EN Whitepaper
Continuous manufacturing of APIs and intermediates under cGMP. A multi-step case study involving a modular continuous plant, and new opportunities for 3D printed reactors
Brought to you by Evonik
Overview

This White Paper reviews opportunities to accelerate development workflow, optimize purity and yield, and reduce capital investment through the application of modular concepts for the continuous manufacturing of APIs or advanced intermediates under cGMP conditions. A new modular continuous plant (MCP) with sufficient design versatility to facilitate rapid, cost-effective manufacturing under cGMP conditions is discussed. As a case study, the development of continuous manufacturing process utilizing Continued Stirred Tank Reactors (CSTR) for Grignard formation and continuous crystallization as well as a PFR for the addition to an electrophile is reviewed.  Emerging continuous manufacturing process opportunities arising out of the development of 3D printed reactors are also highlighted.

Key Objectives´╝Ü
  • Core Advantages in the Continuous Manufacturing for APIs
  • Developing a robust process development workflow for continuous manufacturing
  • Modular continuous plants for cGMP manufacturing of APIs and advanced intermediates

Brought to you by:
Continuous manufacturing of APIs and intermediates under cGMP. A multi-step case study involving a modular continuous plant, and new opportunities for 3D printed reactors
Please complete the form to download the whitepaper.
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) via email, in accordance with the ACS Privacy Policy.

© 2020 American Chemical Society, 1155 16th St NW, Washington, DC 20036, USA. View our Privacy Policy